☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
GE HealthCare
GE HealthCare Reports the P-I Study Data of its Macrocyclic Manganese-Based MRI Contrast Agent
October 7, 2024
GE HealthCare Reports the US FDA’s Approval of Flyrcado (Flurpiridaz F 18) PET Radiotracer for Improved CAD Diagnosis
October 23, 2024
GE HealthCare to Expand its AI-Based Portfolio Through the Acquisition of Intelligent Ultrasound’s Business Unit
July 18, 2024
GE HealthCare and AirStrip Signs a Joint Commercialization Agreement for Integrated Patient Monitoring and Cardiac Data Visualizat...
December 5, 2023
GE HealthCare Launches MyBreastAI Suite for Breast Cancer Detection
November 28, 2023
GE Healthcare Received the US FDA’s 510(k) for New Version of Digital Expert Access & collaborates with IONIC Health
November 22, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.